Gyeonggi, South Korea

Yun Seok Rhee

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Whan in Pharm. Co., Ltd.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yun Seok Rhee. Retrieved from https://idiyas.com/inventor/yun-seok-rhee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yun Seok Rhee in Pharmaceutical Applications.

Introduction

Yun Seok Rhee is a notable inventor based in Gyeonggi, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on topical preparations.

Latest Patents

One of his key patents is titled "Alprostadil alkyl ester-containing composition for external application." This invention relates to a composition of topical preparation that includes alprostadil alkyl ester, an oily vehicle, a skin permeation enhancer, and an anti-irritant agent. This formulation aims to enhance the effectiveness of alprostadil in external applications.

Career Highlights

Yun Seok Rhee is currently associated with Whan in Pharm. Co., Ltd., where he continues to develop and refine pharmaceutical products. His work has led to advancements in the delivery and efficacy of topical medications.

Collaborations

He has collaborated with notable colleagues such as Sun Oh Jeoung and Sang Cheol Chi, contributing to a dynamic research environment that fosters innovation in pharmaceutical sciences.

Conclusion

Yun Seok Rhee's contributions to the field of pharmaceuticals, particularly through his patent on alprostadil alkyl ester compositions, highlight his role as an influential inventor. His ongoing work at Whan in Pharm. Co., Ltd. continues to push the boundaries of topical medication development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…